Social Support, Stressful Life Events, Medication-Taking Self-Efficacy, Psychotic Symptoms on Social Dysfunction: Role of Mediating Effects

Ek-Uma Imkome; Yunibhand J; Chaiyawat W; Nouanthong P

Authors

Ek-Uma Imkome
Yunibhand J
Chaiyawat W
Nouanthong P

Keywords:

social support, medication taking selfefficacy, social dysfunction, path analysis

Abstract

Abstract not found

Downloads

How to Cite

Social Support, Stressful Life Events, Medication-Taking Self-Efficacy, Psychotic Symptoms on Social Dysfunction: Role of Mediating Effects. (2018). Global Journal of Medical Research, 18(F4), 15-23. https://medicalresearchjournal.org/index.php/GJMR/article/view/1594

Download Citation

References

Chen, Lin Sham, P Ball, D Loh, E Hsiao, C (2003) Pre-morbid characteristics and co-morbidity of methamphetamine users with and without psychosis. 33(8), 1407-1414.

M Lambert, P Conus, D Lubman, D Wade, H Yuen, S Moritz, D Naber, P Mcgorry, B Schimmelmann (2005) The impact of substance use disorders on clinical outcome in 643 patients with first‐episode psychosis. 112(2), 141-148.

B Schimmelmann, P Conus, S Cotton, S Kupferschmid, P Mcgorry, M Lambert (2012) Prevalence and impact of cannabis use disorders in adolescents with early onset first episode psychosis. 27(6), 463-469.

D Harris, S Batki (2000) Stimulant psychosis: symptom profile and acute clinical course. 9(1), 28-37.

R Mcketin, J Mclaren, Lubman Hides, L (2006) The prevalence of psychotic symptoms among methamphetamine users. 101(10), 1473-1478.

Manit Srisurapanont, Robert Ali, John Marsden, Agueda Sunga, Kiyoshi Wada, Maristela Monteiro (2003) Psychotic symptoms in methamphetamine psychotic in-patients. 6(4), 347-352.

Elizabeth Jacobs, Daryl Fujii, Jason Schiffman, Iruma Bello (2008) An Exploratory Analysis of Neurocognition in Methamphetamine-induced Psychotic Disorder and Paranoid Schizophrenia. 21(2), 98-103.

Tawandra Rowell-Cunsolo, Stephen Sampong, Montina Befus, Dhritiman Mukherjee, Elaine Larson (2016) Predictors of Illicit Drug Use Among Prisoners. 51(2), 261-267.

María Marquine, Jennifer Iudicello, Erin Morgan, Gregory Brown, Scott Letendre, Ronald Ellis, Reena Deutsch, Steven Woods, Igor Grant, Robert Heaton (2014) "Frontal systems" behaviors in comorbid human immunodeficiency virus infection and methamphetamine dependency. 215(1), 208-216.

K Wilder-Willis, P Shear, Steffen Borkin, J (2002) The relationship between cognitive dysfunction and coping abilities in schizophrenia. 55(3), 259-267.

S Currell, T Christodoulides, J Siitarinen, R Dudley (2016) Patient Factors that Impact upon Cognitive Behavioural Therapy for Psychosis: Therapists' Perspectives. 44(4), 493-498.

James Mahoney, Ari Kalechstein, Richard De La Garza, Thomas Newton (2008) Presence and Persistence of Psychotic Symptoms in Cocaine‐ versus Methamphetamine‐Dependent Participants. 17(2), 83-98.

Rebecca Mcketin, Amanda Baker, Sharon Dawe, Alexandra Voce, Dan Lubman (2017) Differences in the symptom profile of methamphetamine-related psychosis and primary psychotic disorders. 251, 349-354.

Kittirattanapiboon (2001) Brief Psychiatric Rating Scale (BPRS): Suanprung Psychiatric Hospital.

E Imkome, J Yunibhund, W Chaiyawat (2018) A Path Analysis of Psychotic Symptoms Among Persons With Schizophrenia Using Methamphetamines.

Rapin Polsook (2016) Factors influencing medication adherence among persons with post-acute myocardial infarction. 38, 611-620.

E Imkome, J Yunibhand, W Chaiyawat (2017) Development and validation of a Thai stressful life events rating scale for patients with a diagnosis of schizophrenic methamphetamine abuse. 39(2), 205-214.

Somchit Hanucharurnkul (1988) Predictors of self-care in cancer patients receiving radiotherapy. 12(1), 21???27.

E Imkome, J Yunibhand, W Chaiyawat (2016) Testing psychometric properties of the Thai Social Dysfunction Rating Scale (TSDRS) in schizophrenic and methamphetamine abuse Persons. 30(4), 281-287.

R Mcketin, A Kothe, A Baker, Lee Ross, J Lubman, D (2018) Predicting abstinence from methamphetamine use after residential rehabilitation: Findings from the Methamphetamine Treatment Evaluation Study. 37(1), 70-78.

D Perkins (1999) Adherence to antipsychotic medications. 60(21), 25-30.

H Roohafza, M Ramezani, M Sadeghi, M Shahnam, B Zolfagari, N Sarafzadegan (2011) Development and validation of the stressful life event questionnaire. 56(4), 441-448.

Rebecca Mcketin, Dan Lubman, Amanda Baker, Sharon Dawe, Robert Ali (2013) Dose-Related Psychotic Symptoms in Chronic Methamphetamine Users. 70(3), 319.

Eline Rognli, Anders Håkansson, Jonas Berge, Jørgen Bramness (2014) Does the pattern of amphetamine use prior to incarceration predict later psychosis?-A longitudinal study of amphetamine users in the Swedish criminal justice system. 143, 219-224.

Eric Strobl, Shaun Eack, Vaidy Swaminathan, Shyam Visweswaran (2012) Predicting the risk of psychosis onset: advances and prospects. 6(4), 368-379.

Trude Haugland, Marijke Veenstra, Morten Vatn, Astrid Wahl (2013) Improvement in Stress, General Self-Efficacy, and Health Related Quality of Life following Patient Education for Patients with Neuroendocrine Tumors: A Pilot Study. 2013, 1-9.

Ashley Fricks‐gleason, Christopher German, Amanda Hoonakker, Danielle Friend, Kamala Ganesh, Aaron Carver, Glen Hanson, Annette Fleckenstein, Kristen Keefe (2016) An acute, epitope‐specific modification in the dopamine transporter associated with methamphetamine‐induced neurotoxicity. 70(4), 139-146.

Jerry Kokoshka, Roxanne Vaughan, Glen Hanson, Annette Fleckenstein (1998) Nature of methamphetamine-induced rapid and reversible changes in dopamine transporters. 361(2-3), 269-275.

Verónica Sandoval, Evan Riddle, Yvette Ugarte, Glen Hanson, Annette Fleckenstein (2001) Methamphetamine-Induced Rapid and Reversible Changes in Dopamine Transporter Function: AnIn VitroModel. 21(4), 1413-1419.

D Kimhy, K Gill, Gill Brucato, J Vakhrusheva, L Arndt, J Gross, R Girgis (2016) The impact of emotion awareness and regulation on social functioning in individuals at clinical high risk for psychosis. 46(14), 2907-2918.

Mary Kimmel, S Lara-Cinisomo, K Melvin, A Di Florio, A Brandon, S Meltzer-Brody (2016) Treatment of severe perinatal mood disorders on a specialized perinatal psychiatry inpatient unit. 19(4), 645-653.

Catherine Curran, Neetha Byrappa, Andrew Mcbride (2004) Stimulant psychosis: systematic review. 185(3), 196-204.

Tiago Maia, Michael Frank (2017) An Integrative Perspective on the Role of Dopamine in Schizophrenia. 81(1), 52-66.

M Laruelle (2000) The role of endogenous sensitization in the patho-physiology of schizophrenia: implications from recent brain imaging studies. 31, 371-384.

Min Wang, Lin Pei, Paul Fletcher, Shitij Kapur, Philip Seeman, Fang Liu (2010) Schizophrenia, amphetamine-induced sensitized state and acute amphetamine exposure all show a common alteration: increased dopamine D2 receptor dimerization. 3(1), 2.

Kelly Courtney, Lara Ray (2014) Methamphetamine: An update on epidemiology, pharmacology, clinical phenomenology, and treatment literature. 143, 11-21.